The editorial published in Lancet Infectious Diseases October 14th 2021, reviews this issue. There has been widespread coverage in the media of Merck and Ridgeback’s interim results of their phase 2 trial of the antiviral molnupiravir. According to a press...
A paper from America published by the CDC shows that people who have received a vaccine booster are reporting side effects which are similar to those after the second dose. The report relies on more than 12,500 submissions via V-safe, the CDC smartphone based...
An interesting paper published on 9th September 2021, in Nature Human Behaviour by Yang and others looked at the effect of remote working on collaboration amongst information workers. The COVID-19 pandemic caused a rapid shift to full time remote work for...
An interesting comment by Sandmann published on September 22nd 2021 in Lancet Infectious Diseases considers the vaccination rollout in Israel. In The Lancet Infectious Diseases, Eric Haas and colleagues estimated the benefits of the rapid mass roll-out of the Pfizer...
A comment article published by Monti and others in The Lancet September 19th argues that to build a post-pandemic future, in which everyone’s health is protected and promoted, we must learn from the events of the COVID-19 pandemic and previous crises. The...
An interesting article in Science Advances published by Larremore and others in January 2021 looks at this important subject. Because SARS-CoV-2 can spread from individuals with presymptomatic, symptomatic, and asymptomatic infections, the reopening of societies and...
